Effectiveness of cryotherapy delivered by nurses for treatment of cervical preneoplasic lesions

Edwin Pulido, Mauricio González, Óscar Gamboa, Jairo Bonilla, Joaquín Luna, Raúl Murillo
{"title":"Effectiveness of cryotherapy delivered by nurses for treatment of cervical preneoplasic lesions","authors":"Edwin Pulido, Mauricio González, Óscar Gamboa, Jairo Bonilla, Joaquín Luna, Raúl Murillo","doi":"10.7705/biomedica.6966","DOIUrl":null,"url":null,"abstract":"<p><p>Introduction. Cervical cancer is a relevant public health problem for low- and middleincome countries. Follow-up of positive-screened women and compliance with treatment of precancerous lesions are major challenges for these settings.\nObjective. To evaluate the efficacy of cryotherapy delivered by nurses for cervical intraepithelial neoplasia (CIN).\nMaterials and methods. Direct visual inspection with acetic acid and lugol iodine (VIAVILI), and colposcopy/biopsy were performed on women 25 to 59 years old, residents of low-income areas in Bogotá, Colombia. Trained nurses offered immediate cryotherapy to every woman with positive visual inspection. Colposcopy/biopsy was performed before treatment and at a 12-month follow-up. The effectiveness was measured as cure (outcome: no-lesion) and regression (outcome: CIN1) rates of CIN2/3 using colposcopic and histological verification.\nResults. A group of 4.957 women with VIA/VILI was valuated. In total, 499 were screen positive and 472 accepted immediate treatment. A total of 365 women (11 CIN2/3) received cryotherapy by nurses. Cure rate was 72% (95%CI: 39%-94%) and 40% (95%CI: 22%-85%) by colposcopic and histological verification, respectively. Regression rates were 100% and 60%. There were two related non-serious adverse events.\nConclusions. Cure and regression rates by colposcopic verification are like those reported for cryotherapy delivered by doctors. The sample size (CIN2/3) hinders comparisons by type of verification. Our findings support the implementation of screen-and-treat algorithms by nurses among populations with limited access to health services.</p>","PeriodicalId":101322,"journal":{"name":"Biomedica : revista del Instituto Nacional de Salud","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2023-12-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10901276/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Biomedica : revista del Instituto Nacional de Salud","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.7705/biomedica.6966","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction. Cervical cancer is a relevant public health problem for low- and middleincome countries. Follow-up of positive-screened women and compliance with treatment of precancerous lesions are major challenges for these settings. Objective. To evaluate the efficacy of cryotherapy delivered by nurses for cervical intraepithelial neoplasia (CIN). Materials and methods. Direct visual inspection with acetic acid and lugol iodine (VIAVILI), and colposcopy/biopsy were performed on women 25 to 59 years old, residents of low-income areas in Bogotá, Colombia. Trained nurses offered immediate cryotherapy to every woman with positive visual inspection. Colposcopy/biopsy was performed before treatment and at a 12-month follow-up. The effectiveness was measured as cure (outcome: no-lesion) and regression (outcome: CIN1) rates of CIN2/3 using colposcopic and histological verification. Results. A group of 4.957 women with VIA/VILI was valuated. In total, 499 were screen positive and 472 accepted immediate treatment. A total of 365 women (11 CIN2/3) received cryotherapy by nurses. Cure rate was 72% (95%CI: 39%-94%) and 40% (95%CI: 22%-85%) by colposcopic and histological verification, respectively. Regression rates were 100% and 60%. There were two related non-serious adverse events. Conclusions. Cure and regression rates by colposcopic verification are like those reported for cryotherapy delivered by doctors. The sample size (CIN2/3) hinders comparisons by type of verification. Our findings support the implementation of screen-and-treat algorithms by nurses among populations with limited access to health services.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
护士提供的冷冻疗法对宫颈癌前病变的疗效。
导言。宫颈癌是中低收入国家的主要公共卫生问题。这些国家面临的主要挑战是对筛查结果呈阳性的妇女进行随访,以及提供宫颈上皮内瘤变(CIN)的治疗。材料和方法。对波哥大低收入地区 25-59 岁的妇女进行了醋酸和碘溶液直接肉眼检查(VIA-VILI)和阴道镜检查及活检。接受过培训的护士为经肉眼检查呈阳性的妇女立即提供冷冻治疗。在治疗前和随访 12 个月时进行阴道镜检查和活组织检查。通过阴道镜和组织学验证,以治愈率(结果:无病变)和 CIN2/3 消退率(结果:≤NIC1)来评估疗效。结果:4957 名妇女接受了筛查,其中 499 人呈阳性,472 人接受了即时治疗。共有 365 名妇女(11 名 CIN2/3)通过护理接受了冷冻治疗。经阴道镜检查和组织学检查,治愈率分别为 72%(95%CI 39-94%)和 40%(95%CI 22-85%)。消退率分别为 100 % 和 60 %。报告了两例相关的非严重不良事件:结论:通过阴道镜验证的治愈率和消退率与医生冷冻疗法的治愈率和消退率相似。由于 CIN2/3 的样本量较少,因此难以按验证类型进行比较。研究结果支持护士在医疗服务有限的人群中实施 "即看即治 "策略。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Treatment for multidrug-resistant tuberculosis: A comparative analysis of programmatic outcome indicators between Buenaventura and other municipalities of Valle del Cauca, Colombia Association of birth and periodontal disease in Bolivia, Chile and Colombia Fungal coinfection/superinfection in COVID-19 patients in a tertiary hospital in Mexico Correlation between disease severity indices and quality of life measurement tools in atopic dermatitis patients Social determinants of health, the research we need.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1